Abstract
Tetrahydrobiopterin (BH4) has been known to be an essential cofactor for nitric oxide synthase as well as the aromatic amino acid hydroxylases, which are involved in regulation of cellular fates including proliferation, migration and differentiation. In the present study, we report that sepiapterin, a stable form of BH4 precursor, modulates proliferation and migration in human lung cancer cells. Sepiapterin induction of cell proliferation in p53 wild-type A549 cells, but not in p53-deficient H1299 cells, is accompanied by enhanced expression of cell cycle-related proteins such as cyclin-dependent kinase 4 (Cdk4), cyclin D and cyclin E, and reduced expression of Cdk inhibitor p21WAF1/Cip1, demonstrating that sepiapterin-induced mitogenic responses might be associated with p53 expression status in lung cancer cells. In addition, sepiapterin enhances cell migration in A549 cells, but not H1299 cells. Finally, we show that sepiapterin induces A549 cell proliferation and migration through the activation of Akt and p70S6K signaling pathways, as evidenced by using Akt and p70S6K inhibitor. Collectively, these findings indicate that sepiapterin might play differential roles in regulation of cellular fates, depending on the status of p53 expression in lung cancer.
Similar content being viewed by others
References
Adachi M, Taki T, Huang C, Higashiyama M, Doi O, Tsuji T and Miyake M (1998) Reduced integrin a3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J. Clin. Oncol. 16: 1060–1067.
Chen L, Zeng X, Wang J, Briggs SS, O’Neill E, Li J, Leek R, Kerr DJ, Harris AL and Cai S (2010) Roles of tetrahydrobiopterin in promoting tumor angiogenesis. Am. J. Pathol. 177: 2671–2680.
Cho YR, Kim SH, Ko HY, Kim MD, Choi SW and Seo DW (2011) Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70S6K-dependent VEGFR-2 expression. Oncol. Rep. 26: 861–867.
Desgrosellier JS and Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10: 9–22.
Fenton TR and Gout IT (2011) Functions and regulation of the 70kDa ribosomal S6 kinases. Int. J. Biochem. Cell Biol. 43: 47–59.
Fuster JJ, Sanz-Gonzalez SM, Moll UM and Andres V (2007) Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol. Med. 13: 192–199.
Gao L, Pung Y-F, Zhang J, Chen P, Wang T, Li M, Meza M, Toro L and Cai H (2009) Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. Am. J. Physiol. Heart Circ. Physiol. 297: H331–H339.
Gogali A, Charalabopoulos K, Constantopoulos S (2004) Integrin receptors in primary lung cancer. Exp. Oncol. 26, 106–110
Hanahan D and Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646–674.
Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110: 673–687.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ (2006) Cancer statistics, 2006. CA. Cancer J. Clin. 56: 106–130.
Jiang X, Kim B, Lin H, Lee CK, Kim J, Kang H, Lee P, Jung SH, Lee HM and Won KJ (2010) Tetrahydrobiopterin inhibits PDGF-stimulated migration and proliferation in rat smooth muscle cells via the nitric oxide synthase-independent pathway. Korean J. Physiol. Pharmacol. 14: 177–183.
Kreidberg JA (2000) Functions of a3b1 integrin. Curr. Opin. Cell Biol. 12: 548–553.
Lemmon MA and Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141: 1117–1134.
Malumbres M and Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9: 153–166.
Pannirselvam M, Wiehler WB, Anderson T and Triggle CR (2005) Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br. J. Pharmacol. 144: 953–960.
Seo DW, Kim SH, Eom SH, Yoon HJ, Cho YR, Kim PH, Kim YK, Han JW, Diaz T, Wei B, et al. (2008) TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvasc. Res. 76: 145–151.
Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei B and Stetler-Stevenson WG (2003) TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism. Cell 114: 171–180.
Seo DW, Li H, Qu CK, Oh J, Kim YS, Diaz T, Wei B, Han JW and Stetler-Stevenson WG (2006) Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J. Biol. Chem. 281: 3711–3721.
Shang T, Kotamraju S, Zhao H, Kalivendi SV, Hillard CJ and Kalyanaraman B (2005) Sepiapterin attenuates 1-methyl-4-phenylpyridinium-induced apoptosis in neuroblastoma cells transfected with neuronal NOS: Role of tetrahydrobiopterin, nitric oxide, and proteasome activation. Free Radic. Biol. Med. 39: 1059–1074.
Sharma SV, Bell DW, Settleman J and Haber DA (2007) Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7: 169–181.
Sherr CJ and Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13: 1501–1512.
Spiro SG and Silvestri GA (2005) One hundred years of lung cancer. Am. J. Respir. Crit. Care Med. 172(5): 523–529.
Sumi-Ichinose C, Urano F, Kuroda R, Ohye T, Kojima M, Tazawa M, Shiraishi H, Hagino Y, Nagatsu T, Nomura T, et al. (2001) Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. J. Biol. Chem. 276: 41150–41160.
Thony B, Auerbach G and Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J. 347: 1–16.
Viktorsson K, De Petris L and Lewensohn R (2005) The role of p53 in treatment responses of lung cancer. Biochem. Biophys. Res. Commun. 331: 868–880.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cho, YR., Choi, S.W. & Seo, DW. Sepiapterin regulates cell proliferation and migration: its association with integrin α3β1 and p53 in human lung cancer cells. Genes Genom 33, 577–582 (2011). https://doi.org/10.1007/s13258-011-0149-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-011-0149-3